Enhanced hepatic Nrf2 activation after ursodeoxycholic acid treatment in patients with primary biliary cirrhosis

Antioxidants and Redox Signaling

Volumn 13, Issue 3, 2010, Pages 259-268

  Kawata, Kazuhito ^a   Kobayashi, Yoshimasa ^a   Souda, Kenichi ^a   Kawamura, Kinya ^a   Sumiyoshi, Shinichi ^a   Takahashi, Yurimi ^a   Noritake, Hidenao ^a   Watanabe, Shinya ^a   Suehiro, Tomoyuki ^a   Nakamura, Hirotoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; THIOREDOXIN; THIOREDOXIN REDUCTASE 1; TRANSCRIPTION FACTOR NRF2; URSODEOXYCHOLIC ACID; 8-OXO-7-HYDRODEOXYGUANOSINE; ANTIOXIDANT; BILE ACID; DEOXYGUANOSINE; NFE2L2 PROTEIN, HUMAN;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BILE DUCT; CELL PROTECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNODETECTION; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL; MALE; OXIDATIVE STRESS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; BIOPSY; BLOOD; DRUG EFFECTS; GENETICS; LIVER; LIVER CIRRHOSIS, BILIARY; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; BILE ACIDS AND SALTS; BIOPSY; DEOXYGUANOSINE; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS, BILIARY; LIVER NEOPLASMS; MALE; MIDDLE AGED; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; THIOREDOXIN REDUCTASE 1; URSODEOXYCHOLIC ACID;

EID: 77954101086     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2903     Document Type: Article

References (47)

1. Alam J, Stewart D, Touchard C, Boinapally S, Choi AM, and Cook JL. Nrf2, a cap'n'collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem 274: 26071-26078, 1999.
2. Arisawa S, Ishida K, Kameyama N, Ueyama J, Hattori A, TatsumiY,HayashiH, YanoM, Hayashi K,KatanoY,Goto H, Takagi K, and Wakusawa S. Ursodeoxycholic acid induces glutathione synthesis through activation of PI3K=Akt pathway in HepG2cells. Biochem Pharmacol 77: 858-866, 2009.
3. Banning A, Deubel S, Kluth D, Zhou Z, and Brigelius-Flohé R. The GI-GPx gene is a target for Nrf2. Mol Cell Biol 25: 4914-4922, 2005.
4. Bouscarel B, Gettys TW, Fromm H, and Dubner H. Urso-deoxycholic acid inhibits glucagon-induced cAMP formation in hamster hepatocytes: a role for PKC. Am J Physiol. 268: 300-310, 1995.
5. Chen Y, Cai J, and Jones DP. Mitochondrial thioredoxin in regulation of oxidant-induced cell death. FEBS Lett 580: 6596-6602, 2006.
6. Cohen JI, Roychowdhury S, DiBello PM, Jacobsen DW, and Nagy LE. Exogenous thioredoxin prevents ethanol-induced oxidative damage and apoptosis in mouse liver. Hepatology 49: 1709-1717, 2009.
7. Corpechot C, Carrat F, Bahr A, Chrétien Y, Poupon RE, and Poupon R. The effect of ursodeoxycholic acid therapy on the naturalcourseofprimarybiliarycirrhosis.Gastroenterology128: 297-303, 2005.
8. Cullinam SB and Diehl JA. PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival
9. following endoplasmic reticulum stress. J Biol Chem 279: 20108-20117, 2004.
10. Dent P, Fang Y, Gupta S, Studer E, Mitchell C, Spiegel S, and Hylemon PB. Conjugated bile acids promote ERK1=2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and hepatocytes. Hepatology 42: 1291-1299, 2005.
11. Grattagliano I, Portincasa P, Palmieri VO, and Palasciano G. Mutual changes of thioredoxin and nitrosothiols during biliary cirrhosis: results from humans and cholestatic rats. Hepatology 45: 331-339, 2007.
12. HolmgrenA.Thioredoxin. AnnuRev Biochem54: 237-271, 1985.
13. Huang HC, Nguyen T, and Pickett CB. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem 277: 42769-42774, 2002.
14. Ishi T, Itoh K, Takahashi S, Sato H, Yanagawa T, Katoh Y, Bannai S, and Yamamoto M. Transcription factor Nrf2 co-ordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem 275: 16023-16029, 2000.
15. Kadokawa Y, Ohba K, Omagari K, Akazawa S, Hayashida K, Ohnita K, Takeshima F, Mizuta Y, and Kohno S. Intra-cellular balance of oxidative stress and cytoprotective molecules in damaged interlobular bile ducts in autoimmune hepatitis and primary biliary cirrhosis: in situ detection of 8-hydroxydeoxyguanosine and glutathione-S-transferase-pi. Hepatol Res 37: 620-627, 2007.
16. Kang KW, Choi SH, and Kim SG. Peroxynitrite activates NF-E2-related factor 2=antioxidant response element through the pathway of phosphatidylinositol 3-kinase: the role of nitric oxide synthase in rat glutathione S-transferase A2 induction. Nitric Oxide 7: 244-253, 2002.
17. Kang KW, Lee SJ, and Kim SG. Molecular mechanism of nrf2 activation by oxidative stress. Antioxid Redox Signal 7: 1664-1673, 2005.
18. Kawamura K, Kobayashi Y, Kageyama F, Kawasaki T, Na-gasawa M, Toyokuni S, Uchida K, and Nakamura H. Enhanced hepatic lipid peroxidation in patients with primary biliary cirrhosis. Am J Gastroenterol 95: 3596-3601, 2000.
19. Kim YC, Masutani H, Yamaguchi Y, Itoh K, Yamamoto M, and Yodoi J. Hemin-induced activation of the thioredoxin gene by Nrf2: a differential regulation of the antioxidant responsive element by a switch of its binding factors. J Biol Chem 276: 18399-18406, 2001.
20. Kitada T, Seki S, Iwai S, Yamada T, Sakaguchi H, and Wakasa K. In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease. J Hepatol 35: 613-618, 2001.
21. Kogaki H, Fujiwara Y, Yoshiki A, Kitajima S, Tanimoto T, Mitsui A, Shimamura T, Hamuro J, and Ashihara Y. Sensitive enzyme-linked immunosorbent assay for adult T-cell leukemia-derived factor and normal measurement. J Clin Lab Anal 10: 257-261, 1996.
22. Lapenna D, Ciofani G, Festi D, Neri M, Pierdomenico SD, Giamberardino MA, and Cuccurullo F. Antioxidant properties of ursodeoxycholic acid. Biochem Pharmacol 64: 1661-1667, 2002.
23. Lee JS and Surh YJ. Nrf2 as a novel molecular target for chemoprevention. Cancer Lett 224: 171-184, 2005
24. Ljubuncic P, Fuhrman B, Oiknine J, Aviram M, and Bomzon A. Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages. Gut 39: 475-478, 1996.
25. Ludwig J, Dickson ER, and McDonald GSA. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A 379: 103-112, 1978.
26. Mitsuyoshi H, Nakashima T, Sumida Y, Yoh T, Nakajima Y, Ishikawa H, Inaba K, Sakamoto Y, Okanoue T, and Kashima K. Ursodeoxycholic acid protects hepatocytes against oxi-dative injury via induction of antioxidants. Biochem Biophys Res Commun 263: 537-542, 1999.
27. Moi P, Chan K, Asunis I, Cao A, and Kan YW. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2=AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci USA 91: 9926-9930, 1994.
28. Moinova HR and Mulcaphy RT. Up-regulation of the human g-glutamylcysteine synthetase regulatory subunit gene involves binding of Nrf-2 to an electrophile responsive element. Biochem Biophys Res Commun 261: 661-668, 1999.
29. Mustacich D and Powis G. Thioredoxin reductase. Biochem J 346:1-8, 2000.
30. Nakanuma Y and Ohta G. Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis. Gastroenterology 76: 1326-1332, 1979.
31. Nakanuma Y, Tsuneyama K, Gershwin ME, and Yasoshima M. Pathology and immunopathology of primary biliary cirrhosis with emphasis on bile duct lesions: recent progress. Semin Liver Dis 15: 313-328, 1995.
32. Nguyen T, Sherratt PJ, Huang HC, Yang CS, and Pickett CB. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element: degradation of Nrf2 bythe 26S proteasome. J Biol Chem 278: 4536-4541, 2003.
33. Nguyen T, Yang CS, and Pickett CB. The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic Biol Med 37: 433-441, 2004.
34. Okada K, Shouda J, Taguchi K, Maher JM, Ishizaki K, Inoue Y, Ohtsuki M, Goto N, Takeda K, Utsunomiya H, Oda K, Warabi E, Ishii T, Osaka K, Hyodo I, and Yamamoto M. Ursodeoxycholic acid stimulates Nrf2-mediated hepato-cellular transport, detoxification, and antioxidative stress systems in mice. Am J Physiol Gastrointest Liver Physiol 295: 735-747, 2008.
35. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83: 346-356, 1977.
36. Pi J, Bai Y, Reece JM, Williams J, Liu D, Freeman ML, Fahl WE, Shugar D, Liu J, Qu W, Collins S, and Waalkes MP. Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein ki-nase CK2. Free Radic Biol Med 42: 1797-1806, 2007.
37. Podda M, Ghezzi C, Battezzati PM, Bertolini E, Crosignani A, Petroni ML, and Zuin M. Effect of different doses of ursodeoxycholic acid in chronic liver disease. Dig Dis Sci 34: 59S-65S, 1989.
38. Poupon RE, Balkau B, Eschwege E, and Poupon R. A mul-ticenter controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 324: 1548-1554, 1991.
39. Poupon RE, Lindor KD, Pares A, Chazouillères O, Poupon R, and Heathcote EJ. Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis. J Hepatol 39: 12-16, 2003.
40. Qiao L, Yacoub A, Studer E, Gupta S, Pei XY, Grant S, Hylemon PB, and Dent P. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes. Hepatology 35: 779-789, 2002.
41. Sakurai A, Nishimoto M, Himeno S, Imura N, Tsujimoto M, Kunimoto M, and Hara S. Transcriptional regulation of thioredoxin reductase 1 expression by cadmium in vascular endothelial cells: role of NF-E2-related factor-2. J Cell Physiol 203: 529-537, 2005.
42. Schoemaker MH, Conde de la Rosa L, Buist-Homan M, Vrenken TE, Havinga R, Poelstra K, Haisma HJ, Jansen PL, and Moshage H. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 39: 1563-1573, 2004.
43. Sreejayan N and von Ritter C. Effect of bile acids on lipid pe-roxidation: the role of iron. Free Radic Biol Med 25: 50-56, 1998.
44. Toyokuni S. Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int 49: 91-102, 1999.
45. Wild AC, Moinova HR, and Mulcaphy RT. Regulation of gamma- glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J Biol Chem 274: 33627-133436, 1999.
46. Yang H, Ramani K, Xia M, Ko KS, Li TW, Oh P, Li J, and Lu SC. Dysregulation of glutathione synthesis during cho-lestasis in mice: molecular mechanisms and therapeutic implications. Hepatology 49: 1982-1991, 2009.
47. Yu R, Chen C, Mo YY, Hebbar V, Owuor ED, Tan TH, and Kong AN. Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression viaaNrf2-dependent mechanism.JBiol Chem 275: 39907-39913, 2000.